Status:
ACTIVE_NOT_RECRUITING
Creating an Optimized Technology-Based Weight Loss Program for Cardiac Rehabilitation Patients
Lead Sponsor:
The Miriam Hospital
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Obesity
Eligibility:
All Genders
21-75 years
Phase:
NA
Brief Summary
Cardiovascular disease (CVD) is the leading cause of death in the United States. Cardiac rehabilitation (CR) is the main treatment for heart attacks and other types of CVD. It is based on science, it ...
Eligibility Criteria
Inclusion
- currently a participant in The Miriam Hospital's or Newport Hospital's outpatient phase II cardiac rehabilitation program
- medical clearance to participate by the Medical Director
- a body mass index (BMI) between 27-45 kg/m2
- must have a personal computer in their home with internet access
- must read and understand English
- willing to use technology to assist with weight loss
Exclusion
- currently in another weight loss program
- taking weight loss medication
- weight loss of ≥ 5% of body weight in the past 6 months
- currently pregnant, lactating, \< 6 months post-partum, or plans to become pregnant during the next year
- report of loss of consciousness on the Physical Activity Readiness Questionnaire
- New York Heart Association Class IV heart failure
- heart transplant in the last 3 months
- receipt of left ventricular assist device in the last 2 months
- a physician diagnosis of dementia
- a physician prescription for 24 hours of oxygen therapy daily
- coronary artery bypass surgery in the last 4 weeks
- current participation in dialysis
- inability to walk 1 block without stopping
- report of conditions that in the opinion of the investigators would render them potentially unlikely to follow the protocol including terminal illness, substance abuse, eating disorder, or other significant psychiatric problems
Key Trial Info
Start Date :
May 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2024
Estimated Enrollment :
198 Patients enrolled
Trial Details
Trial ID
NCT03845283
Start Date
May 2 2019
End Date
September 1 2024
Last Update
May 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Weight Control and Diabetes Research Center
Providence, Rhode Island, United States, 02903